"Sulfonamides/therapeutic use"[MAJR] - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: "Sulfonamides/therapeutic use"[MAJR] - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
1945	7
1946	19
1947	16
1948	20
1949	8
1951	89
1952	175
1953	214
1954	215
1955	168
1956	267
1957	251
1958	157
1959	86
1960	1
1961	3
1963	6
1964	7
1965	260
1966	420
1967	399
1968	396
1969	382
1970	442
1971	511
1972	465
1973	437
1974	328
1975	362
1976	344
1977	341
1978	367
1979	391
1980	364
1981	473
1982	458
1983	433
1984	473
1985	444
1986	424
1987	458
1988	422
1989	441
1990	421
1991	413
1992	374
1993	428
1994	363
1995	410
1996	393
1997	346
1998	419
1999	460
2000	458
2001	561
2002	566
2003	600
2004	643
2005	732
2006	749
2007	784
2008	836
2009	876
2010	869
2011	966
2012	965
2013	1112
2014	1314
2015	1358
2016	1227
2017	1140
2018	1104
2019	1059
2020	967
2021	713
2022	194
2023	135
2024	100

33,773 results

Page of 3,378

Results by year

Page 1

Dupilumab‐assoziierte Gesichts‐ und Hals‐Dermatitis erfolgreich mit Baricitinib behandelt: Dupilumab‐associated facial and neck dermatitis successfully treated with baricitinib.

Magarreiro-Silva A, Pimenta R, Gouveia AI, Mendes-Bastos P. Magarreiro-Silva A, et al. J Dtsch Dermatol Ges. 2024 May;22(5):704-706. doi: 10.1111/ddg.15355_g. J Dtsch Dermatol Ges. 2024. PMID: 38730513 German. No abstract available.

Comparison of the pleiotropic effect of atorvastatin and rosuvastatin on postmenopausal changes in bone turnover: A randomized comparative study.

Braszak-Cymerman A, Walczak MK, Oduah MT, Ludziejewska A, Bryl W. Braszak-Cymerman A, et al. Medicine (Baltimore). 2024 May 10;103(19):e38122. doi: 10.1097/MD.0000000000038122. Medicine (Baltimore). 2024. PMID: 38728464 Free PMC article. Clinical Trial.

Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1-infected children aged ≥6 to <12 years, using matching placebo tablets: A randomized study.

Van Hemelryck S, Van Landuyt E, Hufkens V, Vanveggel S. Van Hemelryck S, et al. Antivir Ther. 2024 Apr;29(2):13596535241248282. doi: 10.1177/13596535241248282. Antivir Ther. 2024. PMID: 38725258 Clinical Trial.

Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review.

Turjap M, Pelcová M, Gregorová J, Šmak P, Martin H, Štingl J, Peš O, Juřica J. Turjap M, et al. Ther Drug Monit. 2024 Jun 1;46(3):321-331. doi: 10.1097/FTD.0000000000001206. Epub 2024 Apr 30. Ther Drug Monit. 2024. PMID: 38723115

Effect of Carbamazepine on Darunavir Trough Concentrations: When the Dose Can Make the Difference-A Case Study.

Cattaneo D, Caloni B, Caronni S, Calvagna N, Bonini I, Giacomelli A, Gervasoni C. Cattaneo D, et al. Ther Drug Monit. 2024 Jun 1;46(3):277-280. doi: 10.1097/FTD.0000000000001179. Epub 2024 Apr 26. Ther Drug Monit. 2024. PMID: 38723113

[Efficacy and safety of venetoclax combined with hypomethylating agents in the treatment of 83 patients with higher-risk myelodysplastic syndromes].

Liu L, He F, Xu Y, Li T, Li YF, Tang P, Sun L. Liu L, et al. Zhonghua Xue Ye Xue Za Zhi. 2024 Mar 14;45(3):277-283. doi: 10.3760/cma.j.cn121090-20231207-00296. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 38716600 Chinese.

Chlorthalidone vs Hydrochlorothiazide for Hypertension-CV Events: Did the Design Influence the Outcome?

Pareek A, Messerli FH, Ram CVS. Pareek A, et al. J Assoc Physicians India. 2023 Oct;71(10):93. doi: 10.59556/japi.71.0328. J Assoc Physicians India. 2023. PMID: 38716531

Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity.

Takagi A, Miyoshi T, Hayashi T, Koizumi H, Tsumagari K, Yokota C, Nakano T, Matsuo K, Egawa T. Takagi A, et al. Sci Rep. 2024 May 7;14(1):10511. doi: 10.1038/s41598-024-61245-6. Sci Rep. 2024. PMID: 38714773 Free PMC article.

A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.

Manda S, Anz BM 3rd, Benton C, Broun ER, Yimer HA, Renshaw JS, Geils G Jr, Berdeja J, Cruz J, Melear JM, Fanning S, Fletcher L, Li Y, Duan Y, Werner ME, Potluri J, Pai MV, Donnellan WB. Manda S, et al. Hematol Oncol. 2024 May;42(3):e3274. doi: 10.1002/hon.3274. Hematol Oncol. 2024. PMID: 38711253 Clinical Trial.

QbD Enabled Development and Evaluation of Pazopanib Loaded Nanoliposomes for PDAC Treatment.

Shinde A, Panchal K, Patra P, Singh S, Enakolla S, Paliwal R, Chaurasiya A. Shinde A, et al. AAPS PharmSciTech. 2024 May 6;25(5):97. doi: 10.1208/s12249-024-02806-w. AAPS PharmSciTech. 2024. PMID: 38710894

33,773 results

Page of 3,378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

33,773 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

33,773 results

Results by year